Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia

Journal of Infection

Volumn 66, Issue 5, 2013, Pages 415-423

  Viasus, Diego ^a   Garcia Vidal, Carolina ^a   Simonetti, Antonella ^a   Manresa, Frederic ^a,b   Dorca, Jordi ^a,b   Gudiol, Francesc ^a,b   Carratalà, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Albumin; Community acquired pneumonia; Intensive care unit; Mortality; Risk factors

Indexed keywords

ALBUMIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; LEVOFLOXACIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACTEREMIA; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CURB 65; DISEASE SEVERITY; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; HYPOALBUMINEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PLEURA EMPYEMA; PNEUMONIA SEVERITY INDEX; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 84875626634     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.12.007     Document Type: Article

References (25)

1. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
2. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
3. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl. 3):iii1-iii55. Pneumonia Guidelines Committee of the BTS Standards of Care Committee.
4. Huang D.T., Weissfeld L.A., Kellum J.A., Yealy D.M., Kong L., Martino M., et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008, 52:48-58.
5. Krüger S., Welte T. Biomarkers in community-acquired pneumonia. Expert Rev Respir Med 2012, 6:203-214.
6. Huang D.T., Angus D.C., Kellum J.A., Pugh N.A., Weissfeld L.A., Struck J., et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest 2009, 136:823-831.
7. Schuetz P., Suter-Widmer I., Chaudri A., Christ-Crain M., Zimmerli W., Mueller B. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011, 37:384-392. Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) Study Group.
8. Chalmers J.D., Singanayagam A., Scally C., Hill A.T. Admission D-dimer can identify low-risk patients with community-acquired pneumonia. Ann Emerg Med 2009, 53:633-638.
9. Brivet F.G., Jacobs F.M., Prat D., Grigoriu B.D. Sophisticated biomarkers for community-acquired pneumonia severity assessment: gadgets or useful tools?. Intensive Care Med 2008, 34:975-976.
10. Herrmann F.R., Safran C., Levkoff S.E., Minaker K.L. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992, 152:125-130.
11. Hedlund J.U., Hansson L.O., Ortqvist A.B. Hypoalbuminaemia in hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995, 155:1438-1442.
12. Charles P.G., Wolfe R., Whitby M., Fine M.J., Fuller A.J., Stirling R., et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008, 47:375-384. Australian Community-Acquired Pneumonia Study Collaboration.
13. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2009, 58:377-382.
14. Halm E.A., Fine M.J., Marrie T.J., Coley C.M., Kapoor W.N., Obrosky D.S., et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998, 279:1452-1457.
15. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
16. Lee J.H., Kim J., Kim K., Jo Y.H., Rhee J., Kim T.Y., et al. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. J Crit Care 2011, 26:287-294.
17. Rothschild M.A., Oratz M., Schreiber S.S. Serum albumin. Hepatology 1998, 8:385-401.
18. Falcao H., Japiassu A.M. Albumin in critically ill patients: controversies and recommendations. Rev Bras Ter Intensiva 2011, 23:87-95.
19. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256. SAFE Study Investigators.
20. Roberts I., Blackhall K., Alderson P., Bunn F., Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2011, 11:CD001208.
21. Bunn F., Trivedi D., Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2011, 3:CD001319.
22. Finfer S., McEvoy S., Bellomo R., McArthur C., Myburgh J., Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011, 37:86-96. SAFE Study Investigators.
23. Delaney A.P., Dan A., McCaffrey J., Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011, 39:386-391.
24. Krüger S., Ewig S., Giersdorf S., Hartmann O., Suttorp N., Welte T. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010, 182:1426-1434. German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.
25. Nowak A., Breidthardt T., Christ-Crain M., Bingisser R., Meune C., Tanglay Y., et al. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia. Chest 2012, 141:974-982.